Costa Rica vs Guinea-Bissau: HIV-positive TB patients on ART (antiretroviral therapy)
Costa Rica
72.0%
in 2024
Guinea-Bissau
74.0%
in 2024
Costa Rica rank
123rd
Guinea-Bissau rank
121st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Costa Rica
- Guinea-Bissau
How they compare
Guinea-Bissau currently reports 74.0% against 72.0% in Costa Rica, a difference of 2.0%.
The two have swapped places 1 time across 12 shared years of data; in 2005 it was Costa Rica ahead.
Costa Rica ranks 123rd and Guinea-Bissau ranks 121st of 144 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 84.0% | 30.0% | 54.0% | Costa Rica |
| 2010s | 96.8% | 40.3% | 56.5% | Costa Rica |
| 2020s | 90.7% | 70.0% | 20.7% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Costa Rica or Guinea-Bissau?
- Guinea-Bissau, at 74.0% against 72.0% in Costa Rica as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Costa Rica and Guinea-Bissau?
- 2.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Costa Rica and Guinea-Bissau?
- 12 years are reported by both, from 2005 to 2024.
- How do Costa Rica and Guinea-Bissau rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Costa Rica ranks 123rd and Guinea-Bissau ranks 121st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.